260 related articles for article (PubMed ID: 11359520)
1. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons.
Guo X; Dawson VL; Dawson TM
Eur J Neurosci; 2001 May; 13(9):1683-93. PubMed ID: 11359520
[TBL] [Abstract][Full Text] [Related]
2. Immunophilin ligands and GDNF enhance neurite branching or elongation from developing dopamine neurons in culture.
Costantini LC; Isacson O
Exp Neurol; 2000 Jul; 164(1):60-70. PubMed ID: 10877916
[TBL] [Abstract][Full Text] [Related]
3. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506.
Gold BG; Densmore V; Shou W; Matzuk MM; Gordon HS
J Pharmacol Exp Ther; 1999 Jun; 289(3):1202-10. PubMed ID: 10336507
[TBL] [Abstract][Full Text] [Related]
4. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
[TBL] [Abstract][Full Text] [Related]
5. GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum.
Tanaka K; Yoshioka M; Miyazaki I; Fujita N; Ogawa N
Neurosci Lett; 2002 Mar; 321(1-2):45-8. PubMed ID: 11872253
[TBL] [Abstract][Full Text] [Related]
6. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury.
Burnett AL; Becker RE
J Urol; 2004 Jan; 171(1):495-500. PubMed ID: 14665962
[TBL] [Abstract][Full Text] [Related]
7. Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons.
Pong K; Doctrow SR; Baudry M
Brain Res; 2000 Oct; 881(2):182-9. PubMed ID: 11036157
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.
Steiner JP; Hamilton GS; Ross DT; Valentine HL; Guo H; Connolly MA; Liang S; Ramsey C; Li JH; Huang W; Howorth P; Soni R; Fuller M; Sauer H; Nowotnik AC; Suzdak PD
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):2019-24. PubMed ID: 9050897
[TBL] [Abstract][Full Text] [Related]
9. A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease.
Costantini LC; Chaturvedi P; Armistead DM; McCaffrey PG; Deacon TW; Isacson O
Neurobiol Dis; 1998 Aug; 5(2):97-106. PubMed ID: 9746907
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
[TBL] [Abstract][Full Text] [Related]
11. A role for schwann cells in the neuroregenerative effects of a non-immunosuppressive fk506 derivative, jnj460.
Birge RB; Wadsworth S; Akakura R; Abeysinghe H; Kanojia R; MacIelag M; Desbarats J; Escalante M; Singh K; Sundarababu S; Parris K; Childs G; August A; Siekierka J; Weinstein DE
Neuroscience; 2004; 124(2):351-66. PubMed ID: 14980385
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture.
Callier S; Le Saux M; Lhiaubet AM; Di Paolo T; Rostène W; Pelaprat D
J Neurochem; 2002 Jan; 80(2):307-16. PubMed ID: 11902121
[TBL] [Abstract][Full Text] [Related]
13. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
[TBL] [Abstract][Full Text] [Related]
14. FK506 and the role of the immunophilin FKBP-52 in nerve regeneration.
Gold BG
Drug Metab Rev; 1999 Aug; 31(3):649-63. PubMed ID: 10461545
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells.
Tanaka K; Fujita N; Higashi Y; Ogawa N
Neurosci Lett; 2002 Sep; 330(2):147-50. PubMed ID: 12231433
[TBL] [Abstract][Full Text] [Related]
16. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
Park TH; Mytilineou C
Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
[TBL] [Abstract][Full Text] [Related]
17. Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.
Gao JP; Sun S; Li WW; Chen YP; Cai DF
Neurosci Bull; 2008 Jun; 24(3):133-42. PubMed ID: 18500385
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive and non-immunosuppressive immunophilin ligands improve H(2)O(2)-induced cell damage by increasing glutathione levels in NG108-15 cells.
Tanaka K; Fujita N; Yoshioka M; Ogawa N
Brain Res; 2001 Jan; 889(1-2):225-8. PubMed ID: 11166708
[TBL] [Abstract][Full Text] [Related]
19. Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease.
Costantini LC; Cole D; Chaturvedi P; Isacson O
Eur J Neurosci; 2001 Mar; 13(6):1085-92. PubMed ID: 11285005
[TBL] [Abstract][Full Text] [Related]
20. The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle.
Winter C; Schenkel J; Bürger E; Eickmeier C; Zimmermann M; Herdegen T
Neuroscience; 2000; 95(3):753-62. PubMed ID: 10670442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
